Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 18 and 85 years old.
- People who have been diagnosed through a tissue biopsy with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, specifically the high-grade serous or endometrioid types.
- People who are fully active or able to carry out light work (as measured by a standard medical fitness scale called ECOG, scores 0–1).
- People whose cancer has been formally staged as advanced (FIGO 2014 stage IIIB, IIIC, or IVA) and who are either not well enough for, or whose cancer is not suitable for, complete surgical removal at the time of first diagnosis — ideally assessed through a specific keyhole examination procedure called a "Fagotti" diagnostic laparoscopy.
- People for whom a treatment called HIPEC (a heated chemotherapy wash delivered during surgery) is considered a possible option after interval or delayed interval surgery.
- People whose bone marrow, liver, and kidney are functioning well enough to receive chemotherapy and then undergo surgery.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are pregnant.
- People who have, or have had within the three years before starting the study treatment, another separate cancer diagnosis at the same time.
- People who have other health conditions that may make it unsafe to undergo surgery or chemotherapy as planned in the study.
- People whose cancer is of a specific type — mucinous, clear-cell, carcinosarcoma, or low-grade serous adenocarcinoma — as these subtypes are not included in this trial.
- People whose cancer has not responded to, or has worsened during, six cycles of chemotherapy given before surgery — ideally confirmed through a "Fagotti" diagnostic laparoscopy — prior to delayed interval surgery.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dimitrios Tsolakidis, Dr.Prof., Artistotle University of Thessaloniki
Phone: +306946536065
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Overall survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.